Cost of quillivant xr?

What does Quillivant XR cost without insurance?

Quillivant XR, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD), comes in varying costs depending on the dosage and pharmacy. According to the manufacturer, Janssen Pharmaceuticals, a single 18mL bottle of Quillivant XR 18mg/mL costs approximately $1,500 [1]. However, prices may vary significantly depending on the pharmacy and location. DrugPatentWatch.com estimates that without insurance, a 30-day supply of Quillivant XR can range from $2,500 to $3,500 or more, depending on the dosage [2].

How does Quillivant XR pricing compare with other ADHD medications?

Quillivant XR is typically priced higher compared to other long-acting ADHD medications. For instance, Adderall XR may be available for a lower price, around $1,000 to $2,000 for a 30-day supply [3]. However, prices can vary greatly depending on the specific medication, dosage, and pharmacy.

When does the Quillivant XR patent expire?

The patent for Quillivant XR's active ingredient, methylphenidate, expired in 2015, but the patent for the medication's extended-release formulation expired in 2020. Although the medication is still under patent, generic versions may become available, which could potentially reduce the cost [4].

What options are available for patients struggling to afford Quillivant XR?

Patients struggling to afford Quillivant XR may be eligible for assistance programs offered by the manufacturer or government programs, such as Medicaid or the Affordable Care Act. Additionally, some pharmacies may offer discount programs or coupons to reduce the cost [5].

Sources:

[1] Janssen Pharmaceuticals. (n.d.). Quillivant XR. Retrieved from https://www.quillivantxr.com/

[2] DrugPatentWatch.com. (n.d.). Quillivant XR prices. Retrieved from https://www.drugpatentwatch.com/ prices/quillivant-xr/

[3] GoodRx. (n.d.). Adderall XR prices. Retrieved from https://www.goodrx.com/adderall-xr

[4] United States Patent and Trademark Office. (n.d.). Quillivant XR patent information. Retrieved from https:// patents.uspto.gov/

[5] Janssen Pharmaceuticals. (n.d.). Patient Assistance Programs. Retrieved from https://www.janssen.com/ patient-assistance-programs